Half-year report · Q2

Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 42
MetricValuePeriodScopeSource row
Operating income−¥413m2025-01-01 → 2025-06-30StandaloneOperating income
Operating income−¥682m2024-01-01 → 2024-06-30StandaloneOperating income
Ordinary income−¥410m2025-01-01 → 2025-06-30StandaloneOrdinary income
Ordinary income−¥962m2024-01-01 → 2024-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥682m2024-01-01 → 2024-06-30StandaloneOrdinary income
Profit before tax−¥410m2025-01-01 → 2025-06-30StandaloneIncome before income taxes
Profit before tax−¥682m2024-01-01 → 2024-06-30StandaloneIncome before income taxes
Net income−¥412m2025-01-01 → 2025-06-30StandaloneProfit loss
Net income−¥964m2024-01-01 → 2024-12-31StandaloneNet income loss (5-year summary)
Net income−¥683m2024-01-01 → 2024-06-30StandaloneProfit loss
Total assets¥4.4bnat 2025-06-30StandaloneAssets
Total assets¥4.8bnat 2024-12-31StandaloneAssets
Total assets¥5.1bnat 2024-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥68mat 2025-06-30StandaloneLiabilities
Total liabilities¥75mat 2024-12-31StandaloneLiabilities
Net assets / equity¥4.3bnat 2025-06-30StandaloneNet assets
Net assets / equity¥4.7bnat 2024-12-31StandaloneNet assets
Net assets / equity¥5.0bnat 2024-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥4.3bnat 2025-06-30StandaloneCash and deposits
Cash and deposits¥4.7bnat 2024-12-31StandaloneCash and deposits
Cash & equivalents¥4.3bnat 2025-06-30StandaloneCash and cash equivalents
Cash & equivalents¥4.7bnat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥4.9bnat 2024-06-30StandaloneCash and cash equivalents
Cash & equivalents¥5.6bnat 2023-12-31vStandaloneCash and cash equivalents
Operating cash flow−¥357m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥888m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥611m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥02025-01-01 → 2025-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥557,0002024-01-01 → 2024-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥557,0002024-01-01 → 2024-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥20,0002025-01-01 → 2025-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥3m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-9.512025-01-01 → 2025-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-22.282024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-15.792024-01-01 → 2024-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio98.3%at 2025-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio98.3%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio98.3%at 2024-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued43,301,765at 2025-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued43,301,765at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued43,301,765at 2024-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 357
ItemContextValueUnit
Details of employee share option program (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)武田薬品工業株式会社
Address major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)大阪府大阪市中央区道修町4丁目1-1
Name major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)株式会社鶴亀
Address major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)東京都渋谷区千駄ヶ谷4丁目20-1神宮北参道プレックス7階
Name major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)玉田 耕治
Address major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)山口県宇部市
Name major shareholdersCurrentQuarterInstant_No4MajorShareholdersMember
Original text (Japanese)KOREA SECURITIES DEPOSITORY-SAMSUNG(常任代理人 シティバンク、エヌ・エイ東京支店)
Address major shareholdersCurrentQuarterInstant_No4MajorShareholdersMemberText · Plus
Name major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)瀬戸 恭子
Address major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)東京都目黒区
Name major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)大和日台バイオベンチャー投資事業有限責任組合
Address major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)東京都千代田区丸の内1丁目9-1
Name major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)石﨑 秀信
Address major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)東京都目黒区
Name major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)荻原 弘子
Address major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)東京都中野区
Name major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)佐古田 幸美
Address major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)山口県宇部市
Name major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)和田 聡
Address major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)東京都目黒区
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsOtherMember
Original text (Japanese)完全議決権であり、権利内容に何ら限定のない当社における標準となる株式であります。なお、単元株式数は100株であります。
Description issued shares voting rightsCurrentQuarterInstant_SharesLessThanOneUnitMember-
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)ノイルイミューン・バイオテック株式会社
Address of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)東京都港区芝大門二丁目12番10号
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Type1 semi annual financial statements financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Description of fact that consolidated financial statements have not been prepared financial informationCurrentYTDDuration
Original text (Japanese) 当社は、子会社がありませんので、中間連結財務諸表を作成しておりません。
Quarterly balance sheet (text)CurrentYTDDurationText · Plus
Year to quarter end statement of income (text)CurrentYTDDurationText · Plus
Quarterly statement of cash flows (text)CurrentYTDDurationText · Plus
Notes regarding research and development expenses (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Major components of selling general and administrative expenses (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes regarding dividend (text)Prior1YTDDuration_NonConsolidatedMemberText · Plus
Notes when there is significant changes in amounts of equity (text)Prior1YTDDuration_NonConsolidatedMemberText · Plus
Notes regarding dividend (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes when there is significant changes in amounts of equity (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2024-12-31pass
balance sheet identitynon_consolidated 2025-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-06-30pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flownon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-06-30pass